Qurcan
2 known investors
QurCan Therapeutics develops nanoparticle drug delivery technology called TERP to create nanomedicines for cancer and central nervous system diseases, with a focus on improving tissue targeting and reducing toxicity associated with existing approaches.
Investors · 2
Frequently asked questions
- What does Qurcan do?
- QurCan Therapeutics develops nanoparticle drug delivery technology called TERP to create nanomedicines for cancer and central nervous system diseases, with a focus on improving tissue targeting and reducing toxicity associated with existing approaches.
- Who are Qurcan's investors?
- Qurcan's investors include FACIT (Fight Against Cancer Innovation Trust), Toronto Innovation Acceleration Partners.